Laurion Capital Management’s TherapeuticsMD TXMD Stock Holding History

Laurion Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,707	Closed	-$935K	–	881
2021 Q2	$935K	Sell	15,707 -36,116	-70%	-$2.19M	0.01%	450
2021 Q1	$3.47M	Sell	51,823 -14,400	-22%	-$1.13M	0.02%	375
2020 Q4	$4.01M	Buy	+66,223	New	+$4.52M	0.03%	272
2020 Q1	–	Sell	-2,090	Closed	-$253K	–	1089
2019 Q4	$253K	Buy	+2,090	New	+$301K	﹤0.01%	786
2019 Q2	–	Sell	-3,617	Closed	-$881K	–	1184
2019 Q1	$881K	Buy	+3,617	New	+$957K	0.01%	525
2017 Q4	–	Sell	-13,203	Closed	-$3.49M	–	1861
2017 Q3	$3.49M	Buy	+13,203	New	+$3.82M	0.02%	604

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Laurion Capital Management's TXMD Position: Q3 2021 in Review

Laurion Capital Management sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 15,707 shares — an estimated $935K sold.

Laurion Capital Management first reported a position in TXMD in Q3 2017 and held it in 6 quarters. The position peaked at $4.01M in Q4 2020. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

Laurion Capital Management reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
Laurion Capital Management sold 15,707 TherapeuticsMD shares in Q3 2021, an estimated $935K.
Laurion Capital Management first reported a position in TherapeuticsMD in Q3 2017 and held it in 6 quarters.
Laurion Capital Management's TherapeuticsMD position peaked at $4.01M in Q4 2020.
149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Laurion Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.